Science Explorer Back to mapMap
Discussion
Researcher · Arena Pharmaceuticals (United States) · United States

Zhi‐Liang Chu

Zhi‐Liang Chu publishes mostly in Molecular Biology, Organic Chemistry and Endocrinology, Diabetes and Metabolism, on topics such as Diabetes Treatment and Management, Receptor Mechanisms and Signaling and NF-κB Signaling Pathways.

ORCID 0009-0007-2754-7080 OpenAlex
World rank
#1,176,171
of 7,710,434 ranked researchers
Rank in United States
#377,988
of 1,627,098
Works
24
Citations
2.6k
Citations per work
106.4
h-index
14
i10-index 18Top 55% in Molecular Biology
Zhi‐Liang Chu

What does Zhi‐Liang Chu research?

Zhi‐Liang Chu's work is mostly in Biochemistry, Genetics and Molecular Biology (30%), Chemistry (20%), Medicine (17%).

Life Sciences: 10 works · 40.0% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 30.0% of their workMolecular Biology: 5 works · 22.9% of their workCancer Research: 2 works · 7.1% of their workImmunology and Microbiology: 2 works · 10.0% of their workImmunology: 2 works · 10.0% of their workEverything else: 5 works · 22.9% of their workPhysical Sciences: 5 works · 20.0% of their workChemistry: 5 works · 20.0% of their workOrganic Chemistry: 5 works · 20.0% of their workHealth Sciences: 4 works · 17.1% of their workMedicine: 4 works · 17.1% of their workEndocrinology, Diabetes and Metabolism: 3 works · 11.4% of their workSurgery: 1 works · 5.7% of their workTHEIR WORKZhi‐Liang Chu24works
Life Sciences40%Physical Sciences20%Health Sciences17%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology730.0%
    2. Immunology and Microbiology210.0%
  2. Everything else522.9%
    1. Chemistry520.0%
    1. Medicine417.1%
  1. 1Molecular Biology23% of their works
  2. 2Organic Chemistry20% of their works
  3. 3Endocrinology, Diabetes and Metabolism11% of their works
  4. 4Immunology10% of their works
  5. 5Cancer Research7% of their works
  6. 6Surgery6% of their works

Research topics

Which keywords describe Zhi‐Liang Chu's research?

The keywords of their largest research topics: Cardiovascular Outcomes, Inflammation, Type 2 Diabetes, Crystal Structure, G-Protein-Coupled Receptors, Cross-Coupling Reactions, NF-?B and Palladium-Catalyzed.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Cardiovascular Outcomes81 topic
  2. Inflammation82 topics
  3. Type 2 Diabetes81 topic
  4. Crystal Structure61 topic
  5. G-Protein-Coupled Receptors61 topic
  6. Cross-Coupling Reactions41 topic
  7. NF-?B41 topic
  8. Palladium-Catalyzed41 topic
  9. Pancreatic Islets41 topic
  10. Pattern Recognition Receptors41 topic
  11. Signaling41 topic
  12. Toll-like Receptors41 topic
  13. ß-Cell Dysfunction41 topic
  14. Apoptosis31 topic
  15. Cell Death31 topic
  16. Neuropeptides21 topic
  17. Receptors21 topic

Where does Zhi‐Liang Chu work?

Zhi‐Liang Chu's main affiliation in the publication record is Arena Pharmaceuticals (United States), United States.

How many publications and citations does Zhi‐Liang Chu have?

OpenAlex counts 24 works and 2,553 citations for Zhi‐Liang Chu, an h-index of 14, ranking #1,176,171 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Zhi‐Liang Chu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.